Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07238192 · ClinicalTrials.gov registry record · NA

Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD

A NA study of Suicidal Ideation and Posttraumatic Stress Disorder (PTSD), sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
190
Enrollment target
1
Study location

NCT07238192 is a NA study of Suicidal Ideation and Posttraumatic Stress Disorder (PTSD) that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 190 participants, below the 266-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07238192, a NA study of Suicidal Ideation and Posttraumatic Stress Disorder (PTSD), is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
190 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to see if Crisis Response Planning (CRP), a brief strategy designed to help people cope effectively with emotional crises, combined with Cognitive Processing Therapy (CPT), a talk treatment for posttraumatic stress disorder (PTSD), will reduce suicidal thoughts and behaviors.

Interventions

  • BEHAVIORAL Cognitive Processing Therapy

Study Locations (1)

Texas

  • Carl R. Darnall Army Medical Center - Fort Hood

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2026-01-28
Est. Completion 2028-08-31
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT07238192

The ClinicalTrials.gov registry entry for NCT07238192 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (29% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Processing Therapy is the first listed.

NCT07238192 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07238192 about?

NCT07238192 is a clinical study titled "Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD". The purpose of this research is to see if Crisis Response Planning (CRP), a brief strategy designed to help people cope effectively with emotional crises, combined with Cognitive Processing Therapy (CPT), a talk treatment for posttraumatic stress disorder (PTSD), will reduce suicidal thoughts and be...

What is the current status of trial NCT07238192?

This trial is currently recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2026-01-28. Estimated completion is 2028-08-31.

What conditions does trial NCT07238192 study?

This clinical trial studies the following conditions: Suicidal Ideation, Posttraumatic Stress Disorder (PTSD), Suicide Attempt.

What interventions are being tested in trial NCT07238192?

The interventions under investigation include: Cognitive Processing Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT07238192?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07238192 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.